Marfan syndrome follows an autosomal dominant inheritance pattern, meaning a single copy of the mutated gene is enough to cause the condition. If one parent has Marfan syndrome, each child has a 50 percent chance of inheriting it. But about 25 percent of cases appear in people with no family history at all, the result of a brand-new genetic mutation.
The Gene Behind Marfan Syndrome
Marfan syndrome is caused by mutations in the FBN1 gene, located on chromosome 15. This gene provides the instructions for making a protein called fibrillin-1, which gets transported out of cells and into the structural framework that holds tissues together. Once there, fibrillin-1 proteins link up with each other to form tiny thread-like filaments called microfibrils. These microfibrils serve as scaffolding for elastic fibers, the structures that let your skin, ligaments, and blood vessels stretch and bounce back.
Fibrillin-1 also plays a regulatory role. It helps control a growth factor protein that influences how cells grow, divide, and mature. When the microfibril network is intact, this growth factor stays stored and inactive. When the network is disrupted by a faulty fibrillin-1 protein, the growth factor gets released and becomes overactive, triggering abnormal signaling in tissues throughout the body, particularly in bone formation and blood vessel walls.
This is why Marfan syndrome affects so many different parts of the body at once. The connective tissue that fibrillin-1 supports is everywhere: in the aorta, the skeleton, the eyes, the lungs, and the skin. A single gene mutation ripples outward into a wide range of symptoms because the protein it produces is woven into nearly every organ system.
What Autosomal Dominant Means
You carry two copies of most genes, one inherited from each parent. In autosomal dominant conditions like Marfan syndrome, only one defective copy is needed to cause the disorder. The working copy from the other parent isn’t enough to compensate. “Autosomal” means the gene sits on one of the 22 non-sex chromosomes (chromosome 15, in this case), so the condition affects males and females equally.
This pattern creates straightforward math for family planning. A parent with Marfan syndrome has one mutated copy and one normal copy of the FBN1 gene. Each child has a coin-flip chance of receiving either copy: 50 percent risk of inheriting the condition, 50 percent chance of not inheriting it. The odds reset with every pregnancy. Having one affected child doesn’t change the probability for the next.
Children who don’t inherit the mutated gene won’t develop Marfan syndrome and can’t pass it to their own children. The condition doesn’t skip generations through silent carriers the way recessive disorders can.
Cases With No Family History
Roughly one in four people with Marfan syndrome are the first in their family to have it. Their mutation arose spontaneously, either in the egg or sperm cell that formed them or very early in embryonic development. These are called de novo mutations, and they happen without any identifiable cause. Advanced parental age may slightly increase the likelihood, but most spontaneous cases have no clear explanation.
Once a de novo mutation occurs, it becomes heritable. A person who developed Marfan syndrome through a new mutation will pass it on with the same 50 percent probability as someone who inherited it from a parent. The genetics going forward are identical.
Why Severity Varies So Widely
One of the most confusing aspects of Marfan syndrome for families is that two people with the exact same FBN1 mutation can have dramatically different experiences. Even within the same family, one person might have mild joint flexibility and need glasses, while a sibling could face life-threatening aortic complications at a young age.
Researchers have documented roughly 2,900 different mutation sites in the FBN1 gene, which partly explains variation between families. But the variation within families, where everyone shares the same mutation, points to something else. Current research suggests that other genes elsewhere in the genome act as modifiers, dialing the severity up or down. Environmental factors likely play a role too, though the precise mechanisms remain largely unknown. The practical takeaway is that a parent’s experience with Marfan syndrome doesn’t reliably predict how severe the condition will be in their child.
Genetic Testing and Family Planning
Genetic testing can identify the specific FBN1 mutation in someone with Marfan syndrome. Once that mutation is known, it becomes possible to test other family members or future pregnancies for the same change. Prenatal testing through procedures like chorionic villus sampling or amniocentesis can detect the mutation during pregnancy.
There is an important limitation, though. A negative prenatal test confirms the baby didn’t inherit the specific mutation being tested for. It doesn’t rule out a different, previously unidentified mutation in the same gene. This is uncommon but possible.
For couples who want to avoid passing on a known mutation, preimplantation genetic diagnosis is an option. This involves creating embryos through in vitro fertilization, testing each one for the mutation, and implanting only unaffected embryos. This approach requires that the parent’s specific mutation has already been identified through genetic testing.
Some families choose not to pursue any genetic testing during pregnancy, particularly when they feel prepared to raise a child with the condition. The decision is personal, and the available options depend on whether the family’s specific mutation has been characterized.